Insider Transactions in Q4 2024 at Oncocyte Corp (OCX)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 05
2024
|
Andrea S. James Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+27.15%
|
$40,000
$2.29 P/Share
|
Oct 02
2024
|
Andrea S. James Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
33,670
+50.0%
|
$67,340
$2.97 P/Share
|
Oct 02
2024
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
Oct 02
2024
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,315,339
+17.4%
|
$2,630,678
$2.95 P/Share
|